GB Meka
Stocks to watch

PEN

Compare

PENUMBRA INC · Healthcare

$318.34
▼ 0.2%Close 2026-09-30

Live intraday price

Compare with our price levels

T2323.10
T1321.48
E1316.77
E3312.82
SL311.17

Close 2026-09-30: $318.34 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Near buy zone▼ Leaning negative

Near the buy zone — 0.5% above the first entry · 1 whale recently bought

1 month
▼ 1.5%
3 months
▲ 0.6%
1 year
▲ 26.5%
Analyst target
$361.83 +13.7%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$316.77 -0.5%
E2$315.31 -1.0%
E3$312.82 -1.7%
Targets
T1$321.48 1.0%
T2$323.10 1.5%
T3$325.00 2.1%
Stop-loss
SL$311.17 -2.3%
Whale cost ~$336.32 5.6%

Risk : reward 1 : 2.1Moves ~$1.66 a day

⚖️ Positives and risks

✓ Positives (1)
  • ●1 whale bought or added last quarter
! Risks (5)
  • ●2 whales sold or trimmed: George Soros (sold out), Bridgewater (trimmed)
  • ●Lagged the market (S&P 500) by -21% over 6 months
  • ●Price is unusually flat (very low volatility), possibly a pending buyout — levels don't work well
  • ●Earnings down -24% year over year
  • ●High forward P/E of 52x (lots of growth already priced in)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-30Miss -14%

Actual EPS $1.01 · est. $1.18 · After close

▲ 0.4%

Day 1

+0.2%

Next 20 days

2026-05-06In line -5%

Actual EPS $1.01 · est. $1.06 · After close

▲ 0.1%

Day 1

-1.3%

Next 20 days

2026-02-25Beat +6%

Actual EPS $1.18 · est. $1.11 · After close

▲ 1.0%

Day 1

-1.6%

Next 20 days

2025-11-05Beat +5%

Actual EPS $0.97 · est. $0.92 · After close

▲ 17.3%

Day 1

+13.6%

Next 20 days

2025-07-29In line +5%

Actual EPS $0.86 · est. $0.82 · After close

▲ 11.9%

Day 1

+5.0%

Next 20 days

2025-04-23Beat +25%

Actual EPS $0.83 · est. $0.67 · After close

▲ 7.0%

Day 1

-10.6%

Next 20 days

2025-02-18Beat +9%

Actual EPS $0.97 · est. $0.89 · After close

▲ 12.0%

Day 1

-8.0%

Next 20 days

2024-10-30Beat +24%

Actual EPS $0.85 · est. $0.69 · After close

▲ 8.3%

Day 1

+6.7%

Next 20 days

Listen to the earnings call or read the full report on PEN's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$12.5B
Next earnings2026-11-04
P/E (price to earnings)77.8
Forward P/E (on expected earnings)51.9
Revenue growth (YoY)+14.9%
Earnings growth (YoY)-23.5%
Net profit margin+10.7%
ROE+11.4%
Debt to equity (D/E)14%
Dividend yield-
Analyst targets (high / low)$374.00 / $323.00
Number of analysts12
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Sideways → · Sideways →
RSI42
MA50 / MA200$321.60 / $326.76
Distance from MA200-2.6%
MACDPositive
1-year high / low$362.41 / $221.26
vs. S&P 500 (6 months)-20.9%
Volume vs. average1.02×